Literature DB >> 17622951

Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR.

Kandai Nozu1, Xue Jun Fu, Koichi Nakanishi, Norishige Yoshikawa, Hiroshi Kaito, Kyoko Kanda, Rafal Przybyslaw Krol, Ritsuko Miyashita, Hidekazu Kamitsuji, Shoichiro Kanda, Yoshiki Hayashi, Kenichi Satomura, Nobuhiko Shimizu, Kazumoto Iijima, Masafumi Matsuo.   

Abstract

Type III Bartter syndrome (BS) (OMIM607364) is caused by mutations in the basolateral chloride channel CIC-Kb gene (CLCNKB). The CLCNKB gene is sometimes reported as having a large deletion mutation, but all cases reported previously were large homozygous deletions and a large heterozygous deletion is impossible to detect by direct sequencing. This report concerns a genetic analysis of five Japanese patients with type III BS. To identify the mutations, we used polymerase chain reaction (PCR) and direct sequencing. To detect large heterozygous deletion mutations of the CLCNKB gene, we conducted semiquantitative PCR amplification using capillary electrophoresis. The result was that four mutations were identified, comprising one novel 2-bp deletion mutation, an entire heterozygous deletion, and a heterozygous deletion mutation of exons 1 and 2. The nonsense mutation W610X was detected in all patients, and this mutation is likely to constitute a founder effect in Japan. Capillary electrophoresis is a new method and extremely useful for detecting large heterozygous deletions, and should be used to examine type III BS cases in whom only a heterozygous mutation has been detected by direct sequencing. This is the first report to identify large heterozygous deletion mutations in the CLCNKB gene in patients with type III BS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622951     DOI: 10.1203/PDR.0b013e318123fb90

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  20 in total

1.  Chronic renal failure in a boy with classic Bartter's syndrome due to a novel mutation in CLCNKB coding for the chloride channel.

Authors:  Chien-Ming Lin; Jeng-Daw Tsai; Yi-Fen Lo; Ming-Tso Yan; Sung-Sen Yang; Shih-Hua Lin
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

2.  Detection by multiplex ligation-dependent probe amplification of large deletion mutations in the COL4A5 gene in female patients with Alport syndrome.

Authors:  Kandai Nozu; Rafal Przybyslaw Krol; Koichi Nakanishi; Norishige Yoshikawa; Yoshimi Nozu; Yasufumi Ohtsuka; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2009-01-24       Impact factor: 3.714

3.  Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.

Authors:  Kandai Nozu; Shogo Minamikawa; Shiro Yamada; Masafumi Oka; Motoko Yanagita; Naoya Morisada; Shuichiro Fujinaga; China Nagano; Yoshimitsu Gotoh; Eihiko Takahashi; Takahiro Morishita; Tomohiko Yamamura; Takeshi Ninchoji; Hiroshi Kaito; Ichiro Morioka; Koichi Nakanishi; Igor Vorechovsky; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2017-03-09       Impact factor: 3.172

4.  Natural history of genetically proven autosomal recessive Alport syndrome.

Authors:  Masafumi Oka; Kandai Nozu; Hiroshi Kaito; Xue Jun Fu; Koichi Nakanishi; Yuya Hashimura; Naoya Morisada; Kunimasa Yan; Masafumi Matsuo; Norishige Yoshikawa; Igor Vorechovsky; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

5.  Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations.

Authors:  Amar Al Shibli; Hassib Narchi
Journal:  World J Methodol       Date:  2015-06-26

6.  HNF1B alterations associated with congenital anomalies of the kidney and urinary tract.

Authors:  Makiko Nakayama; Kandai Nozu; Yuki Goto; Koichi Kamei; Shuichi Ito; Hidenori Sato; Mitsuru Emi; Koichi Nakanishi; Shigeru Tsuchiya; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2010-02-13       Impact factor: 3.714

7.  Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Authors:  Elsa Seys; Olga Andrini; Mathilde Keck; Lamisse Mansour-Hendili; Pierre-Yves Courand; Christophe Simian; Georges Deschenes; Theresa Kwon; Aurélia Bertholet-Thomas; Guillaume Bobrie; Jean Sébastien Borde; Guylhène Bourdat-Michel; Stéphane Decramer; Mathilde Cailliez; Pauline Krug; Paul Cozette; Jean Daniel Delbet; Laurence Dubourg; Dominique Chaveau; Marc Fila; Noémie Jourde-Chiche; Bertrand Knebelmann; Marie-Pierre Lavocat; Sandrine Lemoine; Djamal Djeddi; Brigitte Llanas; Ferielle Louillet; Elodie Merieau; Maria Mileva; Luisa Mota-Vieira; Christiane Mousson; François Nobili; Robert Novo; Gwenaëlle Roussey-Kesler; Isabelle Vrillon; Stephen B Walsh; Jacques Teulon; Anne Blanchard; Rosa Vargas-Poussou
Journal:  J Am Soc Nephrol       Date:  2017-04-05       Impact factor: 10.121

8.  Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.

Authors:  China Nagano; Kandai Nozu; Naoya Morisada; Masahiko Yazawa; Daisuke Ichikawa; Keita Numasawa; Hiroyo Kourakata; Chieko Matsumura; Satoshi Tazoe; Ryojiro Tanaka; Tomohiko Yamamura; Shogo Minamikawa; Tomoko Horinouchi; Keita Nakanishi; Junya Fujimura; Nana Sakakibara; Yoshimi Nozu; Ming Juan Ye; Hiroshi Kaito; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2018-01-25       Impact factor: 2.801

9.  Detection of large deletion mutations in the COL4A5 gene of female Alport syndrome patients.

Authors:  Kandai Nozu; Rafal Przybyslaw Krol; Yasufumi Ohtsuka; Koichi Nakanishi; Norishige Yoshikawa; Yoshimi Nozu; Hiroshi Kaito; Kyoko Kanda; Yuya Hashimura; Yuhei Hamasaki; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

10.  Hypokalemic rhabdomyolysis in a child with Gitelman's syndrome.

Authors:  Hideki Kumagai; Shizuko Matsumoto; Kandai Nozu
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.